CN103087004A - 一种制备2-亚氨基-四氢噻唑-4-酮衍生物的新方法 - Google Patents

一种制备2-亚氨基-四氢噻唑-4-酮衍生物的新方法 Download PDF

Info

Publication number
CN103087004A
CN103087004A CN2012105461683A CN201210546168A CN103087004A CN 103087004 A CN103087004 A CN 103087004A CN 2012105461683 A CN2012105461683 A CN 2012105461683A CN 201210546168 A CN201210546168 A CN 201210546168A CN 103087004 A CN103087004 A CN 103087004A
Authority
CN
China
Prior art keywords
ketone
thiazolidine
imino
benzyl
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2012105461683A
Other languages
English (en)
Chinese (zh)
Inventor
斯黛芬·阿波勒
马丁·博利
冈泽尔·施密特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actelion Pharmaceuticals Ltd
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of CN103087004A publication Critical patent/CN103087004A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CN2012105461683A 2006-11-23 2007-11-22 一种制备2-亚氨基-四氢噻唑-4-酮衍生物的新方法 Pending CN103087004A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IBPCT/IB2006/054409 2006-11-23
IB2006054409 2006-11-23

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN2007800431941A Division CN101541772B (zh) 2006-11-23 2007-11-22 一种制备2-亚氨基-四氢噻唑-4-酮衍生物的新方法

Publications (1)

Publication Number Publication Date
CN103087004A true CN103087004A (zh) 2013-05-08

Family

ID=39316391

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2012105461683A Pending CN103087004A (zh) 2006-11-23 2007-11-22 一种制备2-亚氨基-四氢噻唑-4-酮衍生物的新方法
CN2007800431941A Active CN101541772B (zh) 2006-11-23 2007-11-22 一种制备2-亚氨基-四氢噻唑-4-酮衍生物的新方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN2007800431941A Active CN101541772B (zh) 2006-11-23 2007-11-22 一种制备2-亚氨基-四氢噻唑-4-酮衍生物的新方法

Country Status (13)

Country Link
US (1) US8263780B2 (enExample)
EP (2) EP2094676B1 (enExample)
JP (1) JP4669564B2 (enExample)
KR (1) KR101255879B1 (enExample)
CN (2) CN103087004A (enExample)
AU (1) AU2007323042B2 (enExample)
CA (1) CA2669069C (enExample)
DK (2) DK2489662T3 (enExample)
ES (2) ES2410793T3 (enExample)
IL (1) IL198847A (enExample)
MX (1) MX2009005048A (enExample)
TW (1) TWI460166B (enExample)
WO (1) WO2008062376A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43833E1 (en) 2003-11-21 2012-11-27 Actelion Pharmaceuticals Ltd. Thiazolidin-4-one derivatives
AU2004295047B2 (en) 2003-11-21 2011-03-10 Laboratoires Juvise Pharmaceuticals 5-(benz- (Z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
US8912340B2 (en) 2006-11-23 2014-12-16 Actelion Pharmaceuticals Ltd. Process for the preparation of 2-imino-thiazolidin-4-one derivatives
DK2278960T4 (da) * 2008-03-17 2020-01-27 Actelion Pharmaceuticals Ltd Dosisregimen til en selektiv sip1 receptoragonist
GB0819182D0 (en) 2008-10-20 2008-11-26 Actelion Pharmaceuticals Ltd Crystalline forms
HRP20200883T1 (hr) 2012-08-17 2020-09-04 Actelion Pharmaceuticals Ltd. Postupak za pripremanje (2z,5z)-5-(3-kloro-4-((r)-2,3-dihidroksipropoksi)benziliden)-2-(propilimino)-3-(o-tolil)tiazolidin-4-ona i međuproizvodi koji se koriste u navedenom postupku
EA036075B1 (ru) 2014-12-11 2020-09-23 Актелион Фармасьютиклз Лтд Схема дозирования для селективного агониста рецептора s1p1
MA41139B1 (fr) 2014-12-11 2026-02-27 Laboratoires Juvise Pharmaceuticals Combinaison pharmaceutique comprenant du ponesimod et son utilisation dans le traitement de la sclérose en plaque
JOP20190207A1 (ar) 2017-03-14 2019-09-10 Actelion Pharmaceuticals Ltd تركيبة صيدلانية تشتمل على بونيسيمود
WO2019060147A1 (en) * 2017-09-19 2019-03-28 Teva Pharmaceuticals Usa, Inc. NEW CRYSTALLINE POLYMORPHE FROM PONESIMOD
US11014897B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof
US11014940B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Thiazolidinone and oxazolidinone compounds and formulations
US11013723B1 (en) 2018-10-16 2021-05-25 Celgene Corporation Solid forms of a thiazolidinone compound, compositions and methods of use thereof
US11186556B1 (en) 2018-10-16 2021-11-30 Celgene Corporation Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof
EP3997076A1 (de) * 2019-07-10 2022-05-18 Bayer Aktiengesellschaft Verfahren zur herstellung von 2-(phenylimino)-1,3-thiazolidin-4-onen
KR20220034818A (ko) * 2019-07-10 2022-03-18 바이엘 악티엔게젤샤프트 2-(페닐이미노)-1,3-티아졸리딘-4-온의 제조 방법
WO2021084068A1 (en) 2019-10-31 2021-05-06 Idorsia Pharmaceuticals Ltd Combination of a cxcr7 antagonist with an s1p1 receptor modulator
KR20200019639A (ko) 2020-01-30 2020-02-24 전대연 만남의 스마트 도착시스템
JP2023513623A (ja) * 2020-02-18 2023-03-31 バイエル・アクチエンゲゼルシヤフト ２－（フェニルイミノ）－３－アルキル－１，３－チアゾリジン－４－オン類の製造方法
EP4387960A1 (en) 2021-08-17 2024-06-26 Teva Czech Industries s.r.o Polymorphs of ponesimod
EP4212156A1 (en) 2022-01-13 2023-07-19 Abivax Combination of 8-chloro-n-(4-(trifluoromethoxy)phenyl)quinolin-2-amine and its derivatives with a s1p receptor modulator
WO2023152691A1 (en) * 2022-02-10 2023-08-17 Metrochem Api Pvt Ltd Process for the preparation of ponesimod and its intermediates thereof
CN117924210A (zh) * 2024-01-22 2024-04-26 赣南师范大学 一种2-亚氨基噻唑烷-4-酮类化合物的制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3077402A (en) * 1954-12-06 1963-02-12 Polaroid Corp Photographic color processes, products, and compositions
NL270002A (enExample) 1960-10-08
OA03835A (fr) * 1970-07-17 1971-12-24 Rhone Poulenc Sa Nouveaux dérivés de la thiazolidine, leur préparation et les compositions qui les contiennent.
PL166269B1 (pl) 1990-04-27 1995-04-28 Orion Yh Tyma Oy Sposób wytwarzania nowych farmakologicznie aktywnych pochodnych katecholul PL PL PL PL PL
TW221689B (enExample) * 1991-08-27 1994-03-11 Otsuka Pharma Co Ltd
DE69429641T2 (de) * 1993-02-26 2002-08-29 Otsuka Pharmaceutical Co., Ltd. Thiazole oder imidazole derivate als maillard reaktion inhibitoren
KR960022486A (ko) 1994-12-29 1996-07-18 김준웅 신규 티아졸리딘-4-온 유도체
US6353006B1 (en) * 1999-01-14 2002-03-05 Bayer Corporation Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents
DE60038687T2 (de) 1999-09-14 2009-05-28 Shionogi & Co., Ltd. 2-imino-1,3-thiazin-derivate
AU767923C (en) * 1999-11-12 2005-03-24 Fujimoto Co., Ltd. Novel 2-(N-cyanoimino)thiazolidin-4-one derivatives
US20050019825A9 (en) * 2002-03-15 2005-01-27 Qing Dong Common ligand mimics: pseudothiohydantoins
AU2003255528B2 (en) 2002-07-10 2009-07-16 Merck Serono Sa Azolidinone-vinyl fused-benzene derivatives
GB0217152D0 (en) 2002-07-24 2002-09-04 Novartis Ag Organic compounds
EP1567112B1 (en) * 2002-11-22 2008-10-15 Smithkline Beecham Corporation THIAZOLIDIN-4-ONES FOR INHIBITING hYAK3 PROTEINS
US20040167192A1 (en) * 2003-01-16 2004-08-26 David Solow-Cordero Methods of treating conditions associated with an Edg-7 receptor
AU2004295047B2 (en) * 2003-11-21 2011-03-10 Laboratoires Juvise Pharmaceuticals 5-(benz- (Z) -ylidene) -thiazolidin-4-one derivatives as immunosuppressant agents
EP1718642A4 (en) * 2004-02-25 2010-11-24 Glaxosmithkline Llc NEW CHEMICAL COMPOUNDS
WO2006094233A1 (en) * 2005-03-03 2006-09-08 Sirtris Pharmaceuticals, Inc. N,n'-dicyclic isothiourea sirtuin modulators
DK2278960T4 (da) * 2008-03-17 2020-01-27 Actelion Pharmaceuticals Ltd Dosisregimen til en selektiv sip1 receptoragonist
GB0819182D0 (en) * 2008-10-20 2008-11-26 Actelion Pharmaceuticals Ltd Crystalline forms

Also Published As

Publication number Publication date
EP2094676A2 (en) 2009-09-02
DK2489662T3 (da) 2014-10-20
BRPI0718986A2 (pt) 2014-02-11
US20100317867A1 (en) 2010-12-16
IL198847A (en) 2015-07-30
WO2008062376A2 (en) 2008-05-29
CA2669069A1 (en) 2008-05-29
EP2489662A1 (en) 2012-08-22
US20110201821A2 (en) 2011-08-18
IL198847A0 (en) 2010-02-17
JP2010510976A (ja) 2010-04-08
AU2007323042B2 (en) 2012-12-20
US8263780B2 (en) 2012-09-11
DK2094676T3 (da) 2013-06-10
KR20090081009A (ko) 2009-07-27
CA2669069C (en) 2015-02-17
WO2008062376A3 (en) 2008-07-10
CN101541772B (zh) 2013-04-17
CN101541772A (zh) 2009-09-23
TWI460166B (zh) 2014-11-11
MX2009005048A (es) 2009-05-25
TW200831474A (en) 2008-08-01
ES2410793T3 (es) 2013-07-03
KR101255879B1 (ko) 2013-04-17
EP2094676B1 (en) 2013-04-10
JP4669564B2 (ja) 2011-04-13
AU2007323042A1 (en) 2008-05-29
EP2489662B1 (en) 2014-08-06
ES2523401T3 (es) 2014-11-25

Similar Documents

Publication Publication Date Title
CN103087004A (zh) 一种制备2-亚氨基-四氢噻唑-4-酮衍生物的新方法
JP2022553230A (ja) ジアステレオマー酒石酸エステルによるラセミ体の分割により２－シアノエチル（４ｓ）－４－（４－シアノ－２－メトキシフェニル）－５－エトキシ－２，８－ジメチル－１，４－ジヒドロ－１，６－ナフチリジン－３－カルボキシレートを調製する方法
CN101993407B (zh) 用于制备西洛多辛的吲哚啉化合物及其制备方法
CN111471003B (zh) 一种立他司特中间体的制备方法
WO2005009991A1 (ja) １，２，４−トリアゾール化合物の製造方法及びその中間体
JP2009132676A (ja) ストロンチウムラネレートおよびその水和物の新規な合成法
CN101146812B (zh) 光学活性铵盐化合物、其制造中间体和制造方法
JP7237385B2 (ja) ３－ブロモ－５－（２－エチルイミダゾ［１，２－ａ］ピリジン－３－カルボニル）－２－ヒドロキシベンゾニトリルの合成
EP2726515B1 (fr) Reactif organostannique alcoxyle supporte, preparation et utilisation pour la synthese de tetrazoles en phase heterogene
JPH0128746B2 (enExample)
JP2007230963A (ja) ２，４−ジ置換ピリジンの製造法
WO2018212216A1 (ja) 光学活性体の製造方法、光学活性体、キラル分子の製造方法およびキラル分子
JP3146596B2 (ja) ３−ヒドロキシメチル−１−プロパルギルイミダゾリジン−２，４−ジオンの製造法
JP2011529868A (ja) ３，４−ジアリール−４，５−ジヒドロ−（１ｈ）−ピラゾール−１−カルボキシアミジン誘導体の合成
JP2010508334A (ja) アミノベンゾシクロヘプテン誘導体、その調製方法及び治療におけるその使用
CN115246781B (zh) 一种沙芬酰胺的制备方法
JP4260911B2 (ja) ピロリジノン誘導体のラセミ化方法
CN108101741B (zh) 一种炔烃水合/不对称氢化串联合成手性醇的方法
JP4144223B2 (ja) クロモン誘導体の製造方法
KR101815001B1 (ko) 고 입체순도를 갖는 4-치환된-5-원고리-설파미데이트-5-포스포네이트 화합물 및 이의 제조방법
WO2005026119A1 (ja) スルホンアミド含有インドール化合物の製造方法
MX2008006378A (en) Organic compounds
EP4509510A1 (en) Synthesis method for 3-phenyl-2,3,4,8,9,10-hexahydropyrano[2,3-f]chromene derivative
JP2009504721A (ja) 化学工程
CN104030997B (zh) 一种用于埃索美拉唑不对称合成的催化剂

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C05 Deemed withdrawal (patent law before 1993)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20130508